EPCAM and cancer: Although it has been shown to be overexpressed in a wide variety of epithelial tumors, EpCAM seems to be associated with a poor prognosis in certain cancer types (colorectal, breast, prostate, gallbladder, ovarian, bladder, pancreas, and adenoid cystic carcinomas).